I conduct research on machine learning models to predict drug combination therapies for antibiotic resistant bacteria. I've improved the capabilities of INIDIGO (INferring Drug Interactions using chemoGenomics and Orthology) to use orthology-based approaches to train and predict for various bacterial species in addition to E. coli.
I co-founded MedLaunch, an engineering design team that builds assistive technologies for disabled people in the local Ann Arbor community. Each year, students work with researchers, physicians, and patients to address unmet needs, with the hopes of delivering a product that improves a person's quality of life.